170 related articles for article (PubMed ID: 8877101)
1. Okadaic acid induces cellular hypertrophy in AKR-2B fibroblasts: involvement of the p70S6 kinase in the onset of protein and rRNA synthesis.
Leicht M; Simm A; Bertsch G; Hoppe J
Cell Growth Differ; 1996 Sep; 7(9):1199-209. PubMed ID: 8877101
[TBL] [Abstract][Full Text] [Related]
2. Late signals from the PDGF receptors leading to the activation of the p70S6-kinase are necessary for the transition from G1 to S phase in AKR-2B cells.
Simm A; Hoppe V; Karbach D; Leicht M; Fenn A; Hoppe J
Exp Cell Res; 1998 Nov; 244(2):379-93. PubMed ID: 9806789
[TBL] [Abstract][Full Text] [Related]
3. The phosphatase inhibitor okadaic acid stimulates the TSH-induced G1-S phase transition in thyroid cells.
Lazzereschi D; Coppa A; Minicione G; Lavitrano M; Fragomele F; Colletta G
Exp Cell Res; 1997 Aug; 234(2):425-33. PubMed ID: 9260913
[TBL] [Abstract][Full Text] [Related]
4. Abbreviated cell cycle progression induced by the serine/threonine protein phosphatase inhibitor okadaic acid at concentrations that promote neoplastic transformation.
Messner DJ; Ao P; Jagdale AB; Boynton AL
Carcinogenesis; 2001 Aug; 22(8):1163-72. PubMed ID: 11470744
[TBL] [Abstract][Full Text] [Related]
5. Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease.
Pei JJ; Gong CX; An WL; Winblad B; Cowburn RF; Grundke-Iqbal I; Iqbal K
Am J Pathol; 2003 Sep; 163(3):845-58. PubMed ID: 12937126
[TBL] [Abstract][Full Text] [Related]
6. Sustained ERK-2 activation in rat glomerular mesangial cells: differential regulation by protein phosphatases.
Schramek H; Schumacher M; Pfaller W
Am J Physiol; 1996 Aug; 271(2 Pt 2):F423-32. PubMed ID: 8770175
[TBL] [Abstract][Full Text] [Related]
7. Role of mTOR in the degradation of IRS-1: regulation of PP2A activity.
Hartley D; Cooper GM
J Cell Biochem; 2002; 85(2):304-14. PubMed ID: 11948686
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2).
Strutz F; Zeisberg M; Renziehausen A; Raschke B; Becker V; van Kooten C; Müller G
Kidney Int; 2001 Feb; 59(2):579-92. PubMed ID: 11168939
[TBL] [Abstract][Full Text] [Related]
9. Heregulin-stimulated acetylcholine receptor gene expression in muscle: requirement for MAP kinase and evidence for a parallel inhibitory pathway independent of electrical activity.
Altiok N; Altiok S; Changeux JP
EMBO J; 1997 Feb; 16(4):717-25. PubMed ID: 9049301
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA
J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167
[TBL] [Abstract][Full Text] [Related]
11. Impairments in both p70 S6 kinase and extracellular signal-regulated kinase signaling pathways contribute to the decline in proliferative capacity of aged hepatocytes.
Liu Y; Gorospe M; Kokkonen GC; Boluyt MO; Younes A; Mock YD; Wang X; Roth GS; Holbrook NJ
Exp Cell Res; 1998 Apr; 240(1):40-8. PubMed ID: 9570919
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of the immunosuppressant rapamycin.
Dumont FJ; Su Q
Life Sci; 1996; 58(5):373-95. PubMed ID: 8594303
[TBL] [Abstract][Full Text] [Related]
13. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
[TBL] [Abstract][Full Text] [Related]
14. Divergence in signal transduction pathways of platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) receptors. Involvement of sphingosine 1-phosphate in PDGF but not EGF signaling.
Rani CS; Wang F; Fuior E; Berger A; Wu J; Sturgill TW; Beitner-Johnson D; LeRoith D; Varticovski L; Spiegel S
J Biol Chem; 1997 Apr; 272(16):10777-83. PubMed ID: 9099730
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
16. Regulation of cyclin-dependent kinase 2 activity by ceramide.
Lee JY; Bielawska AE; Obeid LM
Exp Cell Res; 2000 Dec; 261(2):303-11. PubMed ID: 11112337
[TBL] [Abstract][Full Text] [Related]
17. Multiple intracellular pathways interfere with the activation of a CPP32-like protease induced by serum deprivation of AKR-2B cells.
Schäfer R; Karbach D; Hoppe J
Exp Cell Res; 1998 Apr; 240(1):28-39. PubMed ID: 9570918
[TBL] [Abstract][Full Text] [Related]
18. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
19. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
Benaud CM; Dickson RB
Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
